<DOC>
	<DOC>NCT00245570</DOC>
	<brief_summary>To determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.</brief_summary>
	<brief_title>Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)</brief_title>
	<detailed_description />
	<mesh_term>Asthma, Exercise-Induced</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Physiciandiagnosed exerciseinduced bronchospasm Patient is, other than asthma, not in good, stable health. The Primary Investigator will evaluate whether there are other reasons why the patient may not participate.</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>